Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 26 May 2017
At a glance
- Drugs Cetuximab; Cisplatin; Fluorouracil
- Indications Nasopharyngeal cancer
- Focus Adverse reactions
- 01 May 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 09 Nov 2010 New trial record